Introduction
2,3-Butanediol (2,3-BDO), also known as 2,3-butylene glycol or dimethylene glycol, is a four-carbon diol synthesized as a product of mixed-acid fermentation. Its molecular formula is C 4 H 10 O 2 , with a molecular mass of 90.12 Da, boiling point of [177] [178] [179] [180] [181] [182] o C, and a low freezing point of -60 o C. It appears either as a colorless and odorless liquid or in crystalline form. 2,3-BDO has a wide range of potential uses as a platform chemical and has extensive industrial applications. The dehydration of 2,3-BDO yields the industrial solvent methyl ethyl ketone [4, 14, 63, 65] , and further dehydration produces 1,3-butadiene, the building block of synthetic rubber [57] . In addition, the high octane rating of 2,3-BDO makes it a potential aviation fuel [31] . Furthermore, 2,3-BDO has potential applications in the manufacture of printing inks, perfumes, fumigants, moistening and softening agents, explosives, plasticizers, foods, and pharmaceuticals. The demand for 2,3-BDO is increasing yearly, with a 4-7% growth in its annual production. In addition, the price of 2,3-BDO is relatively high, at approximately 1,600 USD/ton. The growing demand for this compound worldwide has led to a high commercial opportunity [12, 55] . Energy-intensive processes and expensive catalysts are required to produce 2,3-BDO through chemical processes [67] . Bioprocesses, like microbial fermentation, for 2,3-BDO production are less expensive and more environmentally friendly [44] . Microbial 2,3-BDO production has a history of over a hundred years. It was first investigated in 1906 by Harden and Walpole, where the bacterium used in this study was K. pneumoniae [31] . At the time, the chemical synthesis of 2,3-BDO was more expensive than microbial synthesis, limiting the commercial production to fermentation. The microbial production of 2,3-BDO was developed on a commercial scale during World War II, when intense development efforts in the production of diols was stimulated owing to a shortage of the strategic compound 1,3-butadiene (an organic intermediate for synthetic rubber production). Further improvements and developments of the fermentation process diminished as inexpensive petroleumbased routes became available. In the mid-1970s, crude oil prices increased owing to the predicted end of oil reserves. Hence, alternative methods for 2,3-BDO production were considered and the microbial production of 2,3-BDO from biomass received renewed interest in this new wave of "white biotechnology" [20, 46] .
2,3-Butanediol Biosynthesis
2,3-BDO is produced from pyruvate as a part of the mixed-acid fermentation pathway under anaerobic or microaerobic growth in different microorganisms. In addition to 2,3-BDO, other end products are also synthesized through the 2,3-BDO fermentation pathway, including acetate, lactate, formate, succinate, acetoin, and ethanol [31] . The biosynthesis of 2,3-BDO from pyruvate involves three key enzymes: α-acetolactate synthase, α-acetolactate decarboxylase, and 2,3-BDO dehydrogenase (also called acetoin reductase). When culture conditions are not fully aerobic, lactate dehydrogenase, pyruvate-formate lyase, and α-acetolactate synthase act on pyruvate to generate lactate, formate, and 2,3-BDO, respectively (Fig. 2) .
Acetoin, the main precursor of 2,3-BDO, is formed from pyruvate through the action of many enzymes and cofactors. Under anaerobic conditions, α-acetolactate synthase, in the presence of the cofactor thymine diphosphate, catalyzes the condensation of two pyruvate molecules (through a single decarboxylation) into α-acetolactate under low NADH conditions. The α-acetolactate is then decarboxylated to acetoin by α-acetolactate decarboxylase. Under aerobic conditions, α-acetolactate synthase is rapidly and irreversibly inactivated, thus ceasing 2,3-BDO formation. However, in this case, pyruvate is broken down to acetyl-CoA by the pyruvate dehydrogenase multienzyme complex, which is not synthesized in anaerobic environments and is generally inhibited by NADH. The acetyl-CoA formed is then mainly channeled into the tricarboxylic acid (TCA) cycle. The α-acetolactate formed by the action of α-acetolactate synthase can undergo spontaneous decarboxylation, producing diacetyl. The enzyme NADH-linked diacetyl reductase (DAR; also known as acetoin dehydrogenase) can then convert diacetyl to acetoin. Finally, butanediol dehydrogenase (BDH; also known as acetoin reductase (AR)) reduces acetoin to 2,3-BDO, producing different isomeric forms of 2,3-BDO using various acetoin reductase enzymes with different stereospecificities, or by a cyclic pathway (butanediol cycle) that has been reported in different bacteria.
All enzymes and compounds involved in the 2,3-BDO pathway are normally produced during the late log and stationary phases of fermentation, when oxygen-limiting conditions exist. In the butanediol cycle, acetoin is oxidized to diacetyl by acetoin dehydrogenase, and the two resulting diacetyl molecules are converted to acetylacetoin and acetate by the enzyme acetylacetoin synthase. Acetylacetoin is further reduced to acetylbutanediol with different stereospecificities by either NADPH-or NADH-linked acetylacetoin reductase. Different 2,3-BDO stereoisomers are then formed by the action of acetylbutanediol reductase [6, 12, 20, 46, 55] (Fig. 1) . The isomer produced depends on the microorganism; different microorganisms produce different stereoisomers, and generally a mixture of two stereoisomers is formed [6] .
Microorganisms Producing 2,3-Butanediol A number of microorganisms are able to accumulate 2,3-BDO, but few are known to produce significant quantities. Bacteria and yeasts have been studied with the aim of producing 2,3-BDO by microbial fermentation [20] and many inherently produce 2,3-BDO via mixed-acid fermentation, including Aeromonas [59] , Bacillus [15] , Enterobacter, Paenibacillus [36] , and Klebsiella [19, 42, 43, 52, 64] . Different bacterial strains that have been investigated for 2,3-BDO production are summarized in Table 1 . To date, K. pneumoniae, K. oxytoca, and P. polymyxa have been found to be excellent producers of 2,3-BDO.
The biggest advantage of using Klebsiella for 2,3-BDO production is that the species are easy to cultivate and grow rapidly in a simple medium. The stock cultures of this valuable 2,3-BDO-producing strain can also be stored easily [12] . Significantly, in terms of biomass conversion, K. pneumoniae is able to convert all the major sugars present in hemicellulose and cellulose hydrolysates into 2,3-butanediol [2, 16, 17, 64] . Klebsiella typically produces at least twice the amount of 2,3-BDO obtained from P. polymyxa. Recently, the complete genome sequence of 2,3-BDO-producing Klebsiella strains was reported, providing a better basis for understanding the genetic background and improvements in various strains, thereby increasing the yields of 2,3-BDO [49, 50] . Specifically, K. pneumoniae and K. oxytoca have shown the best production of 2,3-BDO by fermentation of a wide range of substrates, including pentoses (xylose and arabinose), hexoses (glucose, mannose, and galactose), and disaccharides (sucrose, lactose, and cellobiose).
Sun et al. [54] reported the utilization of Jerusalem artichoke tubers for 2,3-BDO production through fermentation in K. pneumoniae. Various technologies were investigated, including separate hydrolysis and fermentation (SHF) as well as simultaneous saccharification and fermentation (SSF), during which the pretreated Jerusalem artichoke tubers were hydrolyzed to glucose and fructose with exogenous inulinase. The concentration of 2,3-BDO reached 81.59 and 91.63 g/l after 40 h in batch and fed-batch SSF processes, respectively. The developed SSF methods shortened the overall process time, relieved end-product inhibition, and eliminated the costs of sugar separation. Li et al. [28] further established a 2,3-BDO fermentation process using the Jerusalem artichoke stalk and tuber as feedstock. The Jerusalem artichoke tuber was added to the hydrolysate of the stalk to increase the sugar concentration in fed-batch SSF, and 80.5 g/l of 2,3-BDO plus acetoin was obtained in 68 h.
Another inexpensive substrate, considered the most effective substrate for 2,3-BDO production, is glycerol. Since crude glycerol is continuously generated from the biodiesel process, it is advantageous to develop some means for its utilization. An efficient fermentation was achieved with Klebsiella grown on glycerol [3, 33, 68] . Specifically, the strain K. pneumoniae DSM 2026 is known as an excellent glycerol-fermenting strain. In addition, Biebl et al. [3] have proposed that under microaerobic and low pH conditions, the production of 1,3-propanediol can be reduced and glycerol conversion thus directed predominantly toward the production of 2,3-BDO.
Yu and Saddler [64] used hydrolyzed wood hemicellulose (from acidic and enzymatic methods) for the production of 2,3-BDO by K. pneumoniae, and yields of 0.4-0.5 g/g were obtained. The authors proposed that the higher yields were partially due to the ability of K. pneumoniae to simultaneously ferment uronic acids, such as D-glucuronic and D-galacturonic acid, present in the wood samples.
Current research attempts are focused on using waste products as substrates for 2,3-BDO production, as the overall production cost of 2,3-BDO can decrease and waste can be simultaneously treated without extra disposal costs. Corncob molasses, a waste by-product in xylitol production with high concentrations of hemicellulose-derived arabinose and xylose, has been used as a substrate for the production of 2,3-BDO from K. pneumoniae [58] . The maximum 2,3-BDO concentration obtained was 78.9 g/l after 61 h of fedbatch fermentation.
To improve the economics of the fermentation process, it is desirable to increase the yield of 2,3-BDO while reducing the production of by-products. Ji et al. [19] metabolically engineered a 2,3-BDO hyperproducing K. oxytoca ME-XJ-8 by altering the mixed-acid-2,3-BDO fermentation pathway. Using the modified proton-suicide method, followed by gene insertional inactivation technology, a mutant strain with a reduction in by-products (ethanol, acetoin, lactic acid, and acetic acid) released during 2,3-BDO fermentation was obtained from the wild-type strain and was found to be a promising strain for economical 2,3-BDO production. Fed-batch culturing of the mutant resulted in a final 2,3-BDO titer of up to 130 g/l with a very low level production of by-products.
The improvement of K. pneumoniae for enhanced 2,3-BDO production was recently studied by Kim et al. [25] . Three genes important for 2,3-BDO biosynthesis were identified in K. pneumoniae genomic DNA: acetolactate decarboxylase (budA), acetolactate synthase (budB), and alcohol dehydrogenase (budC). These genes were cloned into pUC18K expression vectors containing the lacZ promoter and the kanamycin resistance gene to generate plasmids pSB1-7. The plasmids were then introduced into K. pneumoniae through electroporation, and 2,3-BDO production increased by 60% in recombinant bacteria compared with the parental strain (Fig. 3) . The maximum 2,3-BDO production levels achieved through fed-batch fermentation with K. pneumoniae SGJSB04 was 101.53 g/l over 40 h (a productivity of 2.54 g/l/h). Thus, the overexpression of genes related to 2,3-BDO synthesis can enhance 2,3-BDO production in K. pneumoniae during fermentation.
Major Virulence Factors Found in K. pneumoniae Klebsiella is a genus of non-motile, Gram-negative, rodshaped bacteria with a prominent polysaccharide-based capsule. The organisms are named after Edwin Klebs, a 19th century German microbiologist. One of its members, K. pneumoniae, is an important opportunistic pathogen that frequently causes urinary tract infections, septicemia, or pneumonia in immunocompromised individuals. K. pneumoniae produces a number of virulence factors that contribute to pathogenesis, including capsular antigens, fimbrial adhesins, siderophores, and O antigens.
The vast majority of K. pneumoniae isolates express a pronounced polysaccharide capsule covering the entire bacterial surface, which forms a characteristic mucoid phenotype when grown on agar plates (Fig. 4) [24] . The capsule is considered to be the dominant virulence factor and in vitro studies have shown that protection against phagocytosis is mediated by the capsule [9, 40, 51, 61] . The capsule consists of a complex layer of surface-associated polysaccharides whose composition varies from strain to strain. In K. pneumoniae, at least 77 distinct polysaccharides (designated the K antigens) have been reported [41] .
Lipopolysaccharide (LPS), the outer component of the bacterial surface, is another important pathogenic determinant in K. pneumoniae. LPS is composed of lipid A, a core oligosaccharide (OS), and an O-antigenic polysaccharide (O-PS). The O-antigen is the outermost component of LPS and consists of repeating units of an oligosaccharide polymer. The O-antigen is highly responsible for the resistance of bacteria to complement-mediated killing, and the outer core aids in the attachment of capsules to the surface.
Another group of virulence factors produced by K. pneumoniae are fimbrial adhesins, protein structures that recognize a wide range of molecular motifs and target bacteria to specific tissue surfaces in the host [26] . K. pneumoniae produces two major types of fimbriae, type 1 fimbriae and type 3 (Mrk) fimbriae [13] . Type 1 fimbriae are thin, rigid, and adhesive surface organelles that exert their adhesive properties through the FimH adhesin, a minor organelle component located at the tips of the fimbriae [7, 26] . The FimH adhesin recognizes mannose-containing glycoproteins present on many mammalian host tissues, such as the surface of the urinary tract, which facilitates bacterial targeting, attachment, and ultimate colonization of the uroepithelium [34] . Type 3 fimbriae are 2 to 4 nm wide and 0.5 to 2 µm long structural organelles predominantly composed of a major-subunit protein (MrkA) in addition to an adhesin (MrkD). They attach to the basolateral surfaces of tracheal epithelial cells and components of basement membranes [47, 56] .
Klebsiella has shown a superior performance in the production of 2,3-BDO compared with other microorganisms because of its broad substrate spectrum, more complete fermentation, and cultural adaptability. Despite this, the pathogenicity of encapsulated Klebsiella species is an obstacle for large-scale 2,3-BDO production. The capsule, lipopolysaccharide, and fimbriae are prominent structural components of the K. pneumoniae cell surface and play important roles in its survival and pathogenicity [47] . The removal of these virulence factors will have a dual benefit, as it reduces the virulence of pathogenic Klebsiella strains and also aids in an economical downstream process during 2,3-BDO production.
Role of K. pneumoniae Virulence Factors in Pathogenesis and Attempts at Their Removal
Recently, research efforts in 2,3-BDO production have greatly focused on the genetic engineering of K. pneumoniae and the removal of its virulence factors. This will surely prove to be advantageous for the efficient and economic production of 2,3-BDO.
Removal of fimbriae. The ability of K. pneumoniae to adhere to host mucosal surfaces is considered a crucial step for the development of infections. In Gram-negative bacteria, adhesion is often mediated by fimbriae, filamentous organelles expressed on the bacterial cell surface. Type 3 fimbriae expressed by K. pneumoniae bind to eukaryotic cells and matrix proteins. Type 3 fimbriae mediate target tissue binding by using MrkD adhesin, which is associated with the fimbrial shaft composed of the MrkA protein. Langstraat et al. [27] reported that the formation of biofilms in vitro by K. pneumoniae strains was influenced by the production of fimbriae on the bacterial surface, as nonfimbriate strains were found to be impaired in their ability to form biofilms. Isogenic fimbriate and nonfimbriate strains of K. pneumoniae expressing green fluorescent protein demonstrated that the absence of type 3 fimbriae affected the formation of dense biofilms.
To determine the genes involved in biofilm formation, Suescun et al. [53] subjected K. pneumoniae MZ2098 to mutagenesis, using the miniTn10Km transposon, and screened for mutants defective in the ability to form biofilms. Selected mutants were analyzed under diverse conditions by varying the culture conditions and growth surfaces. Thirty-seven mutants deficient in biofilm formation were obtained by screening 9,300 transposon-insertion mutants in K. pneumoniae. Three of these mutants had insertions in genes that altered fimbrial formation, and their phenotypes were severely defective in their capacity to adhere to surfaces in vitro.
Johnson et al. [21] used a colony immunoblot screen to identify transposon insertion mutants deficient for type 3 fimbrial surface production. A mutant was found in the mrkI gene that encodes a putative transcriptional regulator. A site-directed mutant of this gene was constructed and found to be deficient for fimbrial surface expression under aerobic conditions (Fig. 5) . The ability of MrkI mutants to form biofilms on both abiotic and extracellular matrixcoated surfaces was significantly decreased.
Schroll et al. [48] described the role of type 1 and type 3 fimbriae in biofilm formation by K. pneumoniae. Isogenic fimbriae mutants of the clinical K. pneumoniae isolate C3091 were constructed, and their ability to form biofilms was checked in a flow cell system by confocal scanning laser microscopy. The wild-type strain was found to form characteristic biofilm, whereas Type 1 fimbriae did not affect biofilm formation (Fig. 6 ) and was found to be downregulated in biofilm-forming cells. In contrast, the expression of type 3 fimbriae strongly promoted biofilm formation. Therefore, type 3, not type 1, fimbriae mediate biofilm formation in K. pneumoniae C3091. Removal of the capsule and lipopolysaccharides. The capsule is a highly viscous slime that firmly adheres to the cell wall of certain bacteria, increasing the viscosity and turbidity of the fermentation media. Capsulated K. pneumoniae cells are difficult to separate from the fermentation broth, hampering the processing of media and other downstream processes. These properties do not favor the use of K. pneumoniae in commercial 2,3-BDO production.
Domenico et al. [8] used sodium salicylate to reduce capsular polysaccharide production in K. pneumoniae. The addition of salicylate (2 to 30 µg/ml) progressively decreased the amount of capsular polysaccharides produced by all strains without significantly inhibiting cell growth. The optimal concentration of salicylate that reduced the polysaccharide production of heavily encapsulated virulent strains (by at least 50%) was found to be 30 µg/ml.
Struve and Krogfelt [52] used in vitro and in vivo models to study the role of the capsule on the virulence of K. pneumoniae. Non-capsulated variants were isolated from translucent parts of bacterial colonies after prolonged growth on agar plates. The absence of the capsule was confirmed by negative capsule staining and by a lack of reaction with the capsule-specific antiserum (Fig. 7) . Results showed that capsule expression dramatically reduces the ability of K. pneumoniae to bind epithelial cells when compared with its non-capsulated variant. K. pneumoniae strains usually express both smooth LPS with O-antigen molecules and capsule polysaccharides (K antigens) on the surface. Regue et al. [45] reported that a single mutation in a gene that codes for a UDP galacturonate 4-epimerase (uge) resulted in a strain with the O -:K -phenotype (lack of capsule and LPS without O-antigen molecules and outer core oligosaccharide). The K. pneumoniae uge mutants were unable to produce experimental urinary tract infections in rats and were completely avirulent in two different animal models (septicemia and pneumonia). The capsule of K. pneumoniae strains contain fucose. The products of the gmd and wcaG genes are responsible for converting mannose to fucose in K. pneumoniae. The K. pneumoniae strain, KpL1, which has a high death rate in infected mice, was mutated by Pan et al. [37] . This mutant had a decreased virulence in infected HepG2 cells. Furthermore, the gmd mutant lost fucose in capsular polysaccharides (compared with wild-type KpL1), increased biofilm formation, and favored interactions with macrophages. The mutant also showed morphological changes, with long filamentous forms and less uniform sizes. Thus, disruption of the fucose synthesis gene affected the pathophysiology of K. pneumoniae, resulting in decreased virulence (Fig. 8) .
The genes involved in K. pneumoniae core LPS biosynthesis are clustered in a region of the K. pneumoniae chromosome (wa), and two different clusters responsible for type 1 and type 2 core biosynthesis have been determined. The core LPS of K. pneumoniae contains two galacturonic acid (GalA) residues, but only one GalA transferase (WabG) has been recognized. Fresno et al. [10] reported the identification of a second GalA transferase involved in K. pneumoniae core oligosaccharide biosynthesis and correlated its enzymatic activity with the pathogen virulence and the amount of cell-bound capsule. The absence of the inner core β-GalA residue decreased virulence in a capsule-dependent experimental mouse pneumonia model. In addition, the mutation resulted in a strong reduction in cell-bound capsule. A K66 Klebsiella strain (a natural isolate) without a functional wabO gene demonstrated reduced levels of cell-bound capsule compared with other K66 strains. Thus, the WabO enzyme plays a significant role in core LPS biosynthesis and determines the level of cell-bound capsule in K. pneumoniae.
The mucoviscosity-associated gene A (magA) of K. pneumoniae contributes to K1 capsular polysaccharide (CPS) biosynthesis. Based on topology analysis and sequence alignment, eight highly conserved amino acid residues of MagA (including R290, P305, G308, G310, H323, N324, G334, and G337) have been recognized in a shared hypothetical loop region of the protein. Lin et al. [29] used site-directed mutagenesis to study the role of eight highly conserved amino acid residues of MagA in CPS production and virulence. Alanine substitutions at R290 or H323 annihilated all of these properties. The G308A mutant was acutely impaired for these functions. The G334A mutant remained mucoid with decreased CPS production, but its virulence was dramatically reduced in vivo. No phenotypic change was noticed for strains harboring magA G310A, G337A, P305A, or N324A mutations. Among the eight candidates, R290, G308, G334, and H323 were found to be functionally significant for CPS synthesis and for the in vitro and in vivo virulence of the strain.
Jung et al. [23] reported the removal of virulence factors from three 2,3-BDO-producing strains, K. pneumoniae KCTC 2242, K. oxytoca KCTC 1686, and K. oxytoca ATCC 43863, through site-specific recombination techniques. A deletion mutation was carried out in the wabG gene encoding a glucosyltransferase, which plays a key role in the synthesis of outer core LPS by attaching the first outer core residue (D-GalAp) to the O-3 position of the L,D-HeppII residue. The morphologies and adhesion properties on epithelial cells showed that the wabG mutant strains were devoid of the outer core LPS, losing their ability to retain the capsular structure. The time profile of growth and 2,3-BDO production from K. pneumoniae KCTC 2242 and K. pneumoniae KCTC 2242 ∆wabG were examined in batch culture with an initial glucose concentration of 70 g/l. Growth was not affected by disrupting the wabG gene, but the production of 2,3-BDO decreased from 31.27 to 22.44 g/l in the mutant compared with the parental strain. However, the production of acetoin and lactate from the wabG mutant strain was negligible, whereas it reached ~5 g/l in the parental strain. Aside from biosafety issues, the Klebsiella strains developed were devoid of their capsule and outer core LPS (Figs. 9 and  10 ), thus having a high potential to be developed as efficient 2,3-BDO producers. The surfaces of wild-type Klebsiella species are covered with a thick layer of capsular polysaccharide. On the other hand, wabG mutant strains were devoid of this layer and thus showed distinctive cell-tocell boundaries. Scale bar is 1 µm (adapted with permission from Jung et al. [23] , copyright (2012) Springer). In response to diminishing petroleum reserves and increasing environmental issues, microbial fermentation is gaining serious attention as a potential substitute for conventional petroleum-based 2,3-BDO production processes. 2,3-BDO has wide applications for the production of many fine chemicals and can also be used as a bulk chemical. Among the number of 2,3-BDO-producing microorganisms, the members of Klebsiella are the most extensively studied. K. pneumoniae species have an unbeatable 2,3-BDO production performance compared with other 2,3-BDOproducing microorganisms. The specific advantage of using K. pneumoniae is its ability to metabolize a wide variety of substrates and the ease of its cultivation. However, despite its superior 2,3-BDO production, the pathogenicity of K. pneumoniae is the major barrier to its commercial use. The persistant interest in K. pneumoniae for 2,3-BDO production creates a need for the removal of this pathogenicity and relieving biosafety concerns. The efficient removal of these pathogenic factors from K. pneumoniae strains holds great potential for economical and efficient 2,3-BDO production through genetic engineering in the near future.
